Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Diagnostic and predictive role of cell-free midkine in malignant pleural effusions.

Lv M, Mou Y, Wang P, Chen Y, Wang T, Hou Y.

J Cancer Res Clin Oncol. 2013 Apr;139(4):543-9. doi: 10.1007/s00432-012-1359-z. Epub 2012 Dec 5.

PMID:
23212314
[PubMed - indexed for MEDLINE]
2.

Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions.

Wang T, Qian X, Wang Z, Wang L, Yu L, Ding Y, Liu B.

Int J Cancer. 2009 Oct 15;125(8):1921-5. doi: 10.1002/ijc.24516.

PMID:
19585499
[PubMed - indexed for MEDLINE]
3.

Midkine mRNA level in peripheral blood mononuclear cells is a novel biomarker for primary non-small cell lung cancer: a prospective study.

Ma Z, Li H, Wang B, Shen Q, Cui E, Min L, Qian F, Ping J, Dai L.

J Cancer Res Clin Oncol. 2013 Apr;139(4):557-62. doi: 10.1007/s00432-012-1357-1. Epub 2012 Dec 7.

PMID:
23224432
[PubMed - indexed for MEDLINE]
4.

Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival.

Lan CC, Wu YK, Lee CH, Huang YC, Huang CY, Tsai YH, Huang SF, Tsao TC.

Jpn J Clin Oncol. 2010 Mar;40(3):234-40. doi: 10.1093/jjco/hyp151. Epub 2009 Nov 22.

PMID:
19933689
[PubMed - indexed for MEDLINE]
Free Article
5.

Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.

Liao ND, Chiang TA, Lee WY.

Cancer Cytopathol. 2013 Dec;121(12):695-702. doi: 10.1002/cncy.21324. Epub 2013 Jul 16.

PMID:
23861325
[PubMed - indexed for MEDLINE]
6.

Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.

Li J, Li ZN, Bao QL, Ge LP, Li XQ, Chen P.

Tumour Biol. 2012 Oct;33(5):1803-10. doi: 10.1007/s13277-012-0439-7. Epub 2012 Jun 14.

PMID:
22696161
[PubMed - indexed for MEDLINE]
7.

Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.

Tang Y, Xu L.

J Exp Clin Cancer Res. 2013 Jun 8;32:37. doi: 10.1186/1756-9966-32-37.

PMID:
23759037
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.

Gaspar MJ, De Miguel J, García Díaz JD, Díez M.

Anticancer Res. 2008 Sep-Oct;28(5B):2947-52.

PMID:
19031938
[PubMed - indexed for MEDLINE]
Free Article
9.

The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.

Xu F, Chen J, Shen HH, Wang XD, Shan J.

J Zhejiang Univ Sci. 2004 Oct;5(10):1286-9.

PMID:
15362202
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions.

Passebosc-Faure K, Li G, Lambert C, Cottier M, Gentil-Perret A, Fournel P, Pérol M, Genin C.

Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6862-7.

PMID:
16203775
[PubMed - indexed for MEDLINE]
Free Article
11.

Detection of mRNAs of GA733 genes by RT-PCR in exfoliated cells of pleural and peritoneal effusions and its clinical values.

Zhang KH, Cao F, Fu QB, Zhu JQ, Chen J, Lv NH.

Intern Med. 2007;46(18):1489-94. Epub 2007 Sep 14.

PMID:
17878632
[PubMed - indexed for MEDLINE]
Free Article
12.

Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.

Villena V, López-Encuentra A, Echave-Sustaeta J, Martín-Escribano P, Ortuño-de-Solo B, Estenoz-Alfaro J.

Cancer. 1996 Aug 15;78(4):736-40.

PMID:
8756365
[PubMed - indexed for MEDLINE]
13.
14.

[Clinical significance of CEA mRNA detection in pleural and peritoneal effusions by real-time fluorescent quantitative RT-PCR].

Zhang X, Cao J, Zheng S, Li XF.

Zhonghua Wai Ke Za Zhi. 2003 Jun;41(6):411-3. Chinese.

PMID:
12895345
[PubMed - indexed for MEDLINE]
15.

Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.

Hsieh TC, Huang WW, Lai CL, Tsao SM, Su CC.

Cancer Cytopathol. 2013 Sep;121(9):483-8. doi: 10.1002/cncy.21283. Epub 2013 Feb 13.

PMID:
23408492
[PubMed - indexed for MEDLINE]
16.

Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.

Bunjhoo H, Wang ZY, Chen HL, Cheng S, Xiong WN, Xu YJ, Cao Y.

Asian Pac J Cancer Prev. 2012;13(7):3495-9.

PMID:
22994784
[PubMed - indexed for MEDLINE]
Free Article
17.

Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion.

Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST, Kang MH, Son SM, Lee YM, Choi SY, Yun SJ, Kim WJ, Lee OJ.

Int J Cancer. 2013 Aug 1;133(3):645-52. doi: 10.1002/ijc.28054. Epub 2013 Feb 25.

PMID:
23354517
[PubMed - indexed for MEDLINE]
18.

[Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].

Yang Z, Xie C.

Zhonghua Jie He He Hu Xi Za Zhi. 2001 Apr;24(4):201-3. Chinese.

PMID:
11802962
[PubMed - indexed for MEDLINE]
19.

Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.

Liao ND, Lee WY.

Cancer Cytopathol. 2012 Aug 25;120(4):269-75. doi: 10.1002/cncy.21191. Epub 2012 Feb 24.

PMID:
22367930
[PubMed - indexed for MEDLINE]
20.

Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.

Riantawan P, Sangsayan P, Bangpattanasiri K, Rojanaraweewong P.

Respiration. 2000;67(1):24-9.

PMID:
10705258
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk